top of page

Perimenopause Brain Fog and the Science Behind It

Writer: Kim Berglin
Kim Berglin
Oct 13
4 min read

A woman in her late forties stands in the kitchen, forgets the word for whisk, and starts to wonder if something is seriously wrong with her mind. Estrogen levels swing wildly during perimenopause, sometimes spiking above typical premenopausal levels before crashing days later, and neuroscientists now tie those swings directly to the hippocampus and prefrontal cortex regions that handle memory and attention. Dr. Lisa Mosconi, who directs the Women's Brain Initiative at Weill Cornell Medicine, has used PET imaging to track estrogen receptors in the living brain and argues the resulting fog is real and temporary for most women. Large surveys across multiple countries back up what she sees in the scanner: a majority of perimenopausal women report forgetfulness and trouble concentrating, even when standardized cognitive tests don't always show a matching decline.

Estrogen Receptors Light Up as Hormones Shift

Mosconi's 2024 study in Scientific Reports scanned 54 healthy women between ages 40 and 65 using a tracer that binds to estrogen receptors in brain tissue. Perimenopausal and postmenopausal women showed progressively higher estrogen receptor density across several hormone-regulated brain networks compared with premenopausal women in the same study. Researchers linked elevated receptor density in some of these regions to both menopause stage and women's own reports of cognitive and mood symptoms, a pairing Mosconi calls evidence that the brain is actively adapting rather than simply declining. "It's astounding how little we know and how little research has been done on women's brain health," she told NeurologyLive in 2024, pointing to decades of neuroscience built almost entirely around male brains and male hormone cycles.

Surveys Across Continents Agree on the Numbers

Zhang's team surveyed 4,063 Chinese women and found hypomnesia, or memory loss, reported by 65.5% of perimenopausal participants and 70.7% of postmenopausal participants, with difficulty concentrating affecting slightly more than half of each group. Lee and Lee surveyed 20,882 Taiwanese women aged 40 to 89 and found memory complaints climbing steadily, from 63.3% premenopause to 66.4% perimenopause to 69.2% postmenopause. Su and colleagues compared 365 Chinese and 362 Japanese women and recorded memory-loss complaints as high as 95% among Japanese participants, with concentration problems nearly doubling between premenopause and perimenopause in the Chinese cohort. Metcalf and colleagues, reviewing this evidence in a 2023 Current Psychiatry Reports paper, note that rural Indian cohorts report similarly high rates of poor memory during the transition, even where cross-sectional studies in Argentina and sub-Saharan Africa failed to confirm a stage-specific effect once researchers controlled for age.

Longitudinal Data Finds a Real, if Narrow, Dip

Researchers following the same women over multiple years, rather than surveying different age groups once, generally find a measurable verbal-memory dip during the perimenopausal window. Psychiatrist Neill Epperson's POAS cohort and the related SWAN study documented declines in verbal memory and learning as women entered perimenopause. Pauline Maki's analysis of 443 women in the Women's Interagency HIV Study, assessed an average of 3.8 times each, found verbal memory and working memory both dipped from premenopause into early perimenopause before partially recovering once the transition completed. A separate cohort tracked by Weber and colleagues identified four distinct cognitive patterns among perimenopausal women through latent profile analysis, ranging from normal performance to specific verbal weaknesses, suggesting the fog isn't one uniform experience but several overlapping ones.

Scans Reveal Amyloid Buildup Without Automatic Decline

Mosconi's earlier brain-imaging work found higher brain-wide amyloid-beta deposits in perimenopausal women compared with men of the same age, an effect amplified among carriers of the APOE4 gene variant linked to Alzheimer's risk. Mosconi found no corresponding decline in cognitive test scores despite that amyloid increase, a disconnect she attributes to the brain's compensating capacity during the transition. Neuroscientists describe the hippocampus, dense with estrogen receptors, as the structure most exposed to falling estrogen, which may explain why forgetfulness clusters around memory tasks rather than reasoning or vocabulary. Removing both ovaries before natural menopause raises dementia risk later in life, while starting hormone therapy soon after that surgery and continuing it until the typical age of menopause appears to offset much of that added risk.

Hormone Therapy Hasn't Proven a Cognitive Fix

Clinical trials testing hormone therapy for cognition during perimenopause have mostly come back disappointing. An eight-week trial of 62 perimenopausal women with depression found no differential cognitive benefit among transdermal estradiol, raloxifene, a phytoestrogen supplement, and placebo. North American Menopause Society guidelines currently advise against prescribing hormone therapy for cognitive complaints alone at any point in the transition, reserving it for vasomotor symptoms like hot flashes and night sweats where trial evidence is stronger. Mosconi's own stance splits the difference: she maintains that perimenopausal brain changes are mostly temporary and reversible once hormones stabilize, telling NYP's Health Matters that "women may be tired, but we are just as sharp," while continuing to study whether early, well-timed estrogen support protects long-term brain health in women with elevated genetic risk.

Bottom Line

Research grounds perimenopause brain fog in estrogen's measurable role in hippocampal and prefrontal function. Surveys from China, Taiwan, Japan, and beyond converge on majorities of women reporting memory lapses and concentration trouble, and longitudinal cohorts confirm a real dip in verbal memory during the transition itself. Important caveats temper that picture: standardized tests don't always capture what women feel day to day, and hormone therapy hasn't shown a reliable cognitive benefit in clinical trials. Most of the measurable decline, meanwhile, resolves once a woman moves fully into postmenopause. Mosconi's imaging work offers a biological mechanism for what millions of women already sensed, even as her own research stops short of calling brain fog permanent damage.

For readers managing the broader metabolic side of this transition, our piece on menopause and midlife metabolic health covers how the same hormonal shifts affect weight and blood sugar regulation.

Sources

NewYork-Presbyterian Health Matters — How to Protect Your Brain Health During Menopause

 
 
 

Comments


bottom of page